High-Volume vs. Standard Plasma Exchange in Acute Liver Failure with Cerebral Edema

This clinical trial is focused on comparing two different methods of plasma exchange in patients who have acute liver failure with brain swelling, a condition known as cerebral edema. The goal is to determine which method is safer and more effective: high-volume plasma exchange or standard-volume plasma exchange. These procedures are important because they might help reduce brain swelling and improve outcomes for patients with severe liver failure, which is a life-threatening condition. The study is crucial as it could lead to better treatment strategies and improve survival rates for people facing this serious medical issue. In the study, participants undergo a brain scan to assess the severity of brain swelling before starting treatment. They receive plasma exchange therapy through a machine that filters and replaces their blood plasma. The high-volume exchange involves replacing a larger amount of plasma compared to the standard volume. Patients are closely monitored for changes in brain swelling and other health markers during and after the treatment sessions. The study also includes routine tests like EEGs to check for seizures and uses medications like hypertonic saline and mannitol to manage brain swelling. If any adverse effects occur, treatments are adjusted accordingly. The overall aim is to find the best plasma exchange method to improve patient recovery and reduce complications.